-
Signature
-
YuFan Stephanie Wang, Attorney-in-Fact
-
Issuer symbol
-
PRGS
-
Transactions as of
-
31 Jan 2024
-
Net transactions value
-
-$1,566,052
-
Form type
-
4
-
Filing time
-
02 Feb 2024, 17:32:28 UTC
Transactions Table
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
| transaction |
PRGS |
Common Stock |
Options Exercise |
$236,175 |
+7,500 |
+31% |
$31.49 |
31,365 |
31 Jan 2024 |
Direct |
|
| transaction |
PRGS |
Common Stock |
Sale |
$429,840 |
-7,500 |
-24% |
$57.31 |
23,865 |
31 Jan 2024 |
Direct |
F1, F2 |
| transaction |
PRGS |
Common Stock |
Options Exercise |
$0 |
+37,164 |
+156% |
$0.000000 |
61,029 |
01 Feb 2024 |
Direct |
F3, F4 |
| transaction |
PRGS |
Common Stock |
Tax liability |
$941,839 |
-16,483 |
-27% |
$57.14 |
44,546 |
01 Feb 2024 |
Direct |
F5 |
| transaction |
PRGS |
Common Stock |
Sale |
$430,548 |
-7,500 |
-17% |
$57.41 |
37,046 |
02 Feb 2024 |
Direct |
F1, F6 |
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
| transaction |
PRGS |
Employee Stock Options (Right to buy) |
Options Exercise |
$0 |
-7,500 |
-19% |
$0.000000 |
32,894 |
31 Jan 2024 |
Common Stock |
7,500 |
$31.49 |
Direct |
F7 |
| transaction |
PRGS |
Restricted Stock Units |
Options Exercise |
$0 |
-37,164 |
-100% |
$0.000000* |
0 |
01 Feb 2024 |
Common Stock |
37,164 |
|
Direct |
F3, F4 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: